179 related articles for article (PubMed ID: 31109168)
1. The current role of radiotherapy and systemic therapy in the multidisciplinary treatment of cholangiocarcinoma.
Soumarová R; Gürlich R; Hajer J; Oliverius M; Kubecová M; Šejdová M; Liberko M; Kološtová K
Cas Lek Cesk; 2019; 158(2):78-82. PubMed ID: 31109168
[TBL] [Abstract][Full Text] [Related]
2. Outcomes from combined chemoradiotherapy in unresectable and locally advanced resected cholangiocarcinoma.
Leong E; Chen WW; Ng E; Van Hazel G; Mitchell A; Spry N
J Gastrointest Cancer; 2012 Mar; 43(1):50-5. PubMed ID: 21049308
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma and the role of radiation and chemotherapy.
Price P
Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
5. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma.
Sumiyoshi T; Shima Y; Okabayashi T; Negoro Y; Shimada Y; Iwata J; Matsumoto M; Hata Y; Noda Y; Sui K; Sueda T
World J Surg; 2018 Sep; 42(9):2910-2918. PubMed ID: 29511872
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma].
Xie ZH; Li J; Xia Y; Shen F
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.
Chang WW; Hsiao PK; Qin L; Chang CL; Chow JM; Wu SY
Radiother Oncol; 2018 Nov; 129(2):284-292. PubMed ID: 30279046
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic Cholangiocarcinoma.
El-Diwany R; Pawlik TM; Ejaz A
Surg Oncol Clin N Am; 2019 Oct; 28(4):587-599. PubMed ID: 31472907
[TBL] [Abstract][Full Text] [Related]
10. [Multidisciplinary treatment of hilar cholangiocarcinoma].
Endo I; Kamiya N; Masunari H; Fujii Y; Tanaka K; Togo S; Shimada H
Nihon Geka Gakkai Zasshi; 2000 May; 101(5):418-22. PubMed ID: 10884991
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
[TBL] [Abstract][Full Text] [Related]
12. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.
Cholangiocarcinoma Working Group
Dig Liver Dis; 2020 Dec; 52(12):1430-1442. PubMed ID: 32952071
[TBL] [Abstract][Full Text] [Related]
13. Locoregional therapy for cholangiocarcinoma.
Kuhlmann JB; Blum HE
Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma.
Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
Merath K; Tiwari A; Parikh AA; Pawlik TM
Future Oncol; 2023 Dec; 19(39):2607-2621. PubMed ID: 38108100
[TBL] [Abstract][Full Text] [Related]
16. [The evaluation of chemoradiotherapy to unresectable hepatobiliary cancers].
Akita H; Yamada T; Sasaki Y; Eguchi H; Ohigashi H; Ishikawa O; Imaoka S
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1727-9. PubMed ID: 16315922
[TBL] [Abstract][Full Text] [Related]
17. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma.
Howell M; Valle JW
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):333-43. PubMed ID: 25966432
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary approaches to intrahepatic cholangiocarcinoma.
Maithel SK; Gamblin TC; Kamel I; Corona-Villalobos CP; Thomas M; Pawlik TM
Cancer; 2013 Nov; 119(22):3929-42. PubMed ID: 23963845
[TBL] [Abstract][Full Text] [Related]
19. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
20. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
